← Back to Search

Behavioural Intervention

Tele-Exergaming for Hospitalized COVID-19 Patients

N/A
Waitlist Available
Led By Sarvari V Yellapragada, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants: Men or women Veterans with COVID-19 or PUI or hospitalized patients with duration of admission anticipated to be greater than 72 hours admitted to MEDVAMC.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the time frame will be from enrollment to 4 weeks post discharge
Awards & highlights

Study Summary

This trial will test the feasibility, acceptability, and effectiveness of the Tele-Exergame mobility program in COVID-19 or PUI (persons under investigation), during hospitalization and examine post-hospitalization outcomes.

Who is the study for?
This trial is for hospitalized COVID-19 patients or those under investigation who can walk with or without help and expect to stay in the hospital for at least 3 days. It includes veterans and others, regardless of common illnesses like pneumonia. People with severe vision/hearing issues, cognitive impairments, terminal illness, ICU patients, non-English/Spanish speakers, and those unable to follow the program are excluded.Check my eligibility
What is being tested?
The study tests a tele-exergame mobility program using tablets that allow patients to exercise through game-based activities while being remotely supervised. The goal is to see if this method is feasible and effective during hospitalization and after discharge compared to standard care.See study design
What are the potential side effects?
Since this intervention involves physical activity through exergames, potential side effects may include typical exercise-related risks such as muscle soreness or strain. However, it's designed considering patient safety; thus serious side effects are not anticipated.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Veterans who have COVID-19 or are suspected to have it, and are expected to stay in the hospital for more than 72 hours at MEDVAMC.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the time frame will be from enrollment to 4 weeks post discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and the time frame will be from enrollment to 4 weeks post discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Exercise dropout rate
Secondary outcome measures
Katz Activities of Daily Living Scale
Other outcome measures
Measuring cognition (MOCA) scale

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Tele-exergame armExperimental Treatment1 Intervention
COVID-19 patients or PUI (persons under investigation) or other inpatients admitted to the MEDVAMC (n=60), with an anticipated length of stay of at least 3 days will be recruited. Participants will be randomized (n=1:1) to either intervention (IG) or control (CG) groups. Both groups will receive standard of care. IG will additionally receive Tele-Exergame MP therapy. Tele-Exergame sessions will range from 3-10 minutes based on patient ability and completed twice daily. They will complete assessments at baseline and at one-month post-hospital discharge.
Group II: Convention care or control groupActive Control1 Intervention
Standard of care only

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,608 Previous Clinical Trials
3,306,189 Total Patients Enrolled
15 Trials studying COVID-19
412,881 Patients Enrolled for COVID-19
Baylor College of MedicineOTHER
1,000 Previous Clinical Trials
6,001,876 Total Patients Enrolled
9 Trials studying COVID-19
1,748 Patients Enrolled for COVID-19
Sarvari V Yellapragada, MDPrincipal InvestigatorMichael E. DeBakey VA Medical Center, Houston, TX

Media Library

Tele-exergaming Tablet (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04743401 — N/A
COVID-19 Research Study Groups: Tele-exergame arm, Convention care or control group
COVID-19 Clinical Trial 2023: Tele-exergaming Tablet Highlights & Side Effects. Trial Name: NCT04743401 — N/A
Tele-exergaming Tablet (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04743401 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are we enrolling patients at this moment for the clinical trial?

"According to the clinicaltrials.gov website, this study is still looking for volunteers. The listing was first created on 7/5/2021 and updated as recently as 7/11/2022."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
Michael E. DeBakey VA Medical Center, Houston, TX
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients
2021. "Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04743401.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top